Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the A...
Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices
About this item
Full title
Author / Creator
Publisher
Atlanta: U.S. Center for Disease Control
Journal title
Language
English
Formats
Publication information
Publisher
Atlanta: U.S. Center for Disease Control
Subjects
More information
Scope and Contents
Contents
During its Feb 2015 meeting, the Advisory Committee on Immunization Practices (ACIP) recommended 9-valent human papillomavirus (HPV) vaccine (9vHPV) as one of three HPV vaccines that can be used for routine vaccination. HPV vaccine is recommended for routine vaccination at age 11 or 12 years. ACIP also recommends vaccination for females aged 13 thr...
Alternative Titles
Full title
Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_reports_1669745076
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_reports_1669745076
Other Identifiers
ISSN
0149-2195
E-ISSN
1545-861X
